FOXO1 and metabolic dysfunction-associated steatohepatitis: To address the hypothesis that myeloid FoxO1 inhibition would suppress hepatic inflammation to prevent the progress of steatosis to NASH, we generated a NASH model by feeding C57BL/6 mice (male, 6 weeks old) a NASH-inducing diet.